![Seeking Alpha](https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/665/normal/Screen_Shot_2016-01-26_at_13.35.16.png?1453815336)
Cassava Sciences: Likely Potential Opportunity From Phase 3 Readout Next Year
Seeking Alpha,
Summary Cassava Sciences is a biotech company focused on developing treatments for Alzheimer's disease with its lead drug…
Summary Cassava Sciences is a biotech company focused on developing treatments for Alzheimer's disease with its lead drug…
03 Apr 2023 An enlargement of the brain ventricle might set off alarm bells in a neurologist's office.
A novel blood test evaluating brain-derived tau detected Alzheimer’s-related neurodegeneration and differentiated Alzheimer’s…
Ein neuartiger Bluttest zur Beurteilung von aus dem Gehirn stammendem Tau wies Alzheimer-bedingte Neurodegeneration nach und…